Yervoy 200 MG/40 ML vial 40ML
Ended Awarded
- Contract number
- SPE2DB26FDS50
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,916
Award facts
- Contract value 100% obligated
- $45,915.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Yervoy (ipilimumab) 200 mg/40 mL vials. This $45,915.98 firm fixed-price delivery order is scheduled for completion by November 10, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract received no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
Yervoy is a specialty immunotherapy medication used in oncology treatment regimens, reflecting the breadth of pharmaceutical products supplied by AmerisourceBergen through its federal medical supply contracts. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen maintains extensive federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain. The SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB26FDS50?
SPE2DB26FDS50 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDS50 worth?
The government has obligated $45,916 on SPE2DB26FDS50.
Is contract SPE2DB26FDS50 an order under another contract?
Yes. SPE2DB26FDS50 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDS50 competed?
The extent of competition for SPE2DB26FDS50 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award